Circulating tumor cells (CTCs) in SWOG S1216: A phase 3 multicenter trial in metastatic hormone sensitive prostate cancer (mHSPC).

Authors

null

Amir Goldkorn

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Amir Goldkorn , Melissa Plets , Neeraj Agarwal , Maha Hussain , Primo Lara Jr., Daniel A. Vaena , Gary R. MacVicar , Tony Crispino , Andrea Lynne Harzstark , Przemyslaw Twardowski , Catherine M. Tangen , Cory Michael Hugen , Tong Xu , Yucheng Xu , Jacek K. Pinski , Sue A. Ingles , Celestia S. Higano , Nicholas J. Vogelzang , Ian Murchie Thompson Jr., David I. Quinn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Circulating Biomarkers

Clinical Trial Registration Number

NCT01809691

Citation

J Clin Oncol 34, 2016 (suppl; abstr 11516)

DOI

10.1200/JCO.2016.34.15_suppl.11516

Abstract #

11516

Poster Bd #

213

Abstract Disclosures